| Ticker | Name | Price | 30-Day Trend | Pipeline | Segment | Valuation | Therapeutic Area | Market Capital | Volume | P/E RATIO | Insiders | EPS | D/E RATIO | Live-Cash | Burn Rate | Ebitda | Runway | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | Agilent Technologies, Inc. | 155.08 0.20 % | +13.2% | N/A (Dx) | Diagnostics | Diagnostics | 43.80 B | 3.21 M | 30.98 | -220.75 K | 5.01 | 0.49 | 1.81 B | 116.33 M | 1.84 B | 15.11 | PROFITABLE | |
AAPG | Ascentage Pharma Group International - American Depository Shares | 16.9 0.66 % | -17.6% | Pharma Clinical | — | 1.58 B | 4.86 K | 0.00 | - | -1.94 | 1.50 | 171.93 M | 14.56 M | -156.72 M | 24.28 | — | ||
AARD | Aardvark Therapeutics, Inc. | 6.81 -6.07 % | +1.3% | Pharma Clinical | — | 149.03 M | 111.94 K | 0.00 | - | -3.19 | 0.00 | 73.87 M | 5.87 M | -74.68 M | 12.30 | STABLE | ||
ABBV | AbbVie Inc. | 262.9 -1.09 % | +3.0% | Pharma Commercial | — | Cardiovascular Disease, Dermat Read More | 464.49 B | 3.31 M | 73.63 | -10.81 M | 3.57 | 0.00 | 6.57 B | - | 29.19 B | - | PROFITABLE | |
ABCL | AbCellera Biologics Inc. | 12.24 -2.08 % | +98.1% | Biotech Clinical | — | 3.75 B | 5.04 M | 0.00 | 1.50 M | -0.54 | 0.15 | 540.10 M | 12.79 M | -181.09 M | 41.40 | PROFITABLE | ||
ABEO | Abeona Therapeutics Inc. | 6.01 -3.22 % | -12.7% | Pharma Commercial | — | 343.68 M | 1.22 M | 0.00 | -3.08 M | -1.10 | 0.16 | 146.83 M | 5.83 M | -89.14 M | 24.90 | HEALTHY | ||
ABOS | Acumen Pharmaceuticals, Inc. | 2.99 -3.55 % | +35.5% | Biotech Clinical | — | 215.96 M | 235.09 K | 0.00 | -110.38 K | -1.45 | 0.36 | 110.20 M | 6.03 M | -114.43 M | 18.00 | STABLE | ||
ABSI | Absci Corporation | 9.22 -4.26 % | +12.3% | Biotech Clinical | — | 1.58 B | 2.68 M | 0.00 | -510.74 K | -0.71 | 0.03 | 201.14 M | 9.19 M | -117.14 M | 21.60 | STABLE | ||
ABT | Abbott Laboratories | 114.1 -1.75 % | +16.6% | MedTech Commercial | MedTech | Analgesia/Anesthesiology/Anti- Read More | 197.44 B | 6.96 M | 31.46 | -47.09 M | 3.63 | 0.65 | 7.29 B | - | 11.19 B | - | PROFITABLE | |
ABUS | Arbutus Biopharma Corporation | 5.19 -0.19 % | +9.7% | Pharma Clinical | — | 1.03 B | 4.60 M | 6.71 | - | 0.77 | 0.02 | 92.63 M | 2.01 M | 155.14 M | 45.90 | HEALTHY | ||
ABVC | ABVC BioPharma, Inc. | 0.711 -11.11 % | -34.7% | Pharma Clinical | — | 18.88 M | 99.91 K | 0.00 | - | -0.27 | 0.25 | 94.36 K | 81.00 K | -7.55 M | 0.90 | CRITICAL | ||
ABVX | Abivax SA | 116.52 -1.20 % | -15.5% | Pharma Clinical | — | 10.17 B | 512.04 K | 0.00 | - | -5.25 | 0.08 | 606.82 M | 17.17 M | -300.56 M | 32.98 | — | ||
ACAD | ACADIA Pharmaceuticals Inc. | 29.58 -3.24 % | +14.6% | Pharma Commercial | — | 5.10 B | 1.34 M | 13.40 | -2.98 M | 2.21 | 0.04 | 956.47 M | 10.29 M | 92.71 M | 82.74 | PROFITABLE | ||
A ACB | Aurora Cannabis Inc. Common Shares | 4 -0.25 % | +56.8% | Tools & Services Clinical | Tools & Services | 259.37 M | 1.41 M | 0.00 | - | -1.15 | NaN | - | - | - | NaN | — | ||
ACET | Adicet Bio, Inc. | 8.95 -0.56 % | +7.2% | Pharma Clinical | — | 83.79 M | 119.34 K | 0.00 | - | -10.57 | 0.10 | 118.19 M | 6.61 M | -107.78 M | 17.40 | STABLE | ||
ACH | Accendra Health, Inc. | 1.22 5.17 % | -69.6% | — | — | — | 93.43 M | 776.30 K | 0.00 | - | -3.95 | 0.00 | 7.65 M | 8.67 M | 344.06 M | 0.50 | CRITICAL | |
A ACHC | Acadia Healthcare Company, Inc. | 30.58 2.38 % | -6.0% | — | — | — | 2.85 B | 2.03 M | 0.00 | -35.95 K | -11.89 | NaN | 158.47 M | - | - | NaN | PROFITABLE | |
ACHV | Achieve Life Sciences, Inc. | 8.27 1.22 % | +36.4% | Biotech Clinical | — | 851.00 M | 1.32 M | 0.00 | -330.28 K | -1.10 | 1.40 | 187.30 M | 3.59 M | -52.23 M | 51.80 | HEALTHY | ||
ACIU | AC Immune SA | 2.85 -2.40 % | +30.7% | Pharma Clinical | — | 290.05 M | 269.06 K | 0.00 | - | -0.82 | 0.14 | 33.82 M | - | - | 0.00 | — | ||
A ACOG | Alpha Cognition Inc. | 9.41 -3.49 % | +12.0% | Pharma | — | 204.89 M | 251.84 K | 0.00 | 4.94 M | -1.08 | -2.72 | 41.38 M | 2.29 M | -11.45 M | 17.80 | STABLE | ||
A ACON | Aclarion, Inc. Common Stock | 2.39 -4.02 % | -8.0% | Diagnostics Clinical | Diagnostics | 6.89 M | 103.62 K | 0.00 | 125.67 K | -3.19 | NaN | 16.29 M | 886.00 K | - | 17.90 | STABLE | ||
ACRS | Aclaris Therapeutics, Inc. | 6.19 -5.28 % | +17.9% | Pharma Clinical | — | 865.51 M | 1.74 M | 0.00 | - | -0.51 | 0.01 | 170.62 M | 6.62 M | -77.86 M | 25.30 | HEALTHY | ||
ACRV | Acrivon Therapeutics, Inc. | 2.08 -4.59 % | +20.3% | Pharma Clinical | — | 89.03 M | 160.13 K | 0.00 | -39.44 K | -1.73 | 0.03 | 89.96 M | 4.95 M | -81.01 M | 17.90 | STABLE | ||
ACTU | Actuate Therapeutics, Inc. | 1.78 12.66 % | +0.3% | Pharma Clinical | — | 42.75 M | 3.30 M | 0.00 | - | -0.85 | 0.11 | 4.43 M | 1.47 M | -21.83 M | 2.80 | CRITICAL | ||
ACXP | Acurx Pharmaceuticals, Inc. | 1.43 1.42 % | -11.9% | Pharma Clinical | — | Gastroenterology, Infectious D Read More | 6.15 M | 146.08 K | 0.00 | - | -1.75 | 0.00 | 10.66 M | 570.00 K | -7.63 M | 18.40 | STABLE | |
ADAG | Adagene Inc. | 3.85 0.79 % | +8.7% | Pharma Clinical | — | 182.43 M | 122.15 K | 0.00 | -65.74 K | -0.37 | 0.12 | 74.52 M | 1.31 M | -20.91 M | 56.95 | — | ||
ADCT | ADC Therapeutics SA | 1.05 0.96 % | -23.0% | Pharma Commercial | — | 133.55 M | 1.95 M | 0.00 | - | -0.76 | 0.00 | 219.11 M | 3.94 M | -104.12 M | 55.40 | HEALTHY | ||
ADGM | Adagio Medical Holdings, Inc | 0.522 -5.09 % | -1.8% | MedTech Clinical | MedTech | 11.59 M | 329.39 K | 0.00 | - | -1.22 | 4.21 | 7.74 M | 1.75 M | -18.39 M | 4.10 | DISTRESSED | ||
ADIL | Adial Pharmaceuticals, Inc | 5.94 2.06 % | +101.4% | Pharma Clinical | — | Analgesia/Anesthesiology/Anti- Read More | 15.60 M | 64.63 K | 0.00 | 206.33 K | -22.01 | 0.00 | 28.71 M | 2.12 M | -7.53 M | 13.30 | STABLE | |
ADMA | ADMA Biologics Inc | 9.63 -0.93 % | +8.6% | Biotech Commercial | — | Infectious Disease (viral), In Read More | 2.16 B | 1.37 M | 12.77 | - | 0.75 | 0.52 | 136.02 M | 10.69 M | 214.82 M | 12.92 | PROFITABLE | |
ADPT | Adaptive Biotechnologies Corporation | 26.16 -0.34 % | +18.2% | Biotech Clinical | — | 4.18 B | 1.39 M | 0.00 | -176.69 M | -0.40 | 0.96 | 371.74 M | 2.13 M | -28.80 M | 173.70 | HEALTHY | ||
A ADUS | Addus HomeCare Corp. | 120.71 -0.31 % | +7.5% | — | — | — | 2.25 B | 153.60 K | 21.41 | -27.01 K | 5.64 | NaN | 99.57 M | - | - | NaN | PROFITABLE | |
ADVB | Advanced Biomed Inc. | 9.24 0.65 % | +83.7% | N/A (Dx) | Diagnostics | Diagnostics | 15.27 M | 570.87 K | 2.89 | - | 3.20 | 0.08 | 2.60 M | 80.00 K | -81.53 K | 29.30 | HEALTHY | |
ADXN | Addex Therapeutics Ltd | 4.23 8.46 % | -30.0% | Pharma Clinical | — | Analgesia/Anesthesiology/Anti- Read More | 7.71 M | 97.93 K | 0.00 | - | -9.10 | 0.01 | 2.07 M | 219.23 K | -3.40 M | 9.43 | — | |
AEMD | Aethlon Medical, Inc. | 2.28 -5.00 % | -30.9% | MedTech Clinical | MedTech | 1.48 M | 28.89 K | 0.00 | -4.47 K | -13.17 | 0.06 | 4.93 M | 632.00 K | -6.82 M | 7.50 | CAUTION | ||
AEON | AEON Biopharma, Inc. | 0.2515 18.69 % | -24.9% | Pharma Clinical | — | 6.62 M | 4.05 M | 0.00 | 243.46 K | -1.09 | 0.00 | 3.43 M | 1.23 M | -18.81 M | 2.50 | CRITICAL | ||
AGEN | Agenus Inc. | 8.25 -1.32 % | +62.2% | Biotech Clinical | — | 371.42 M | 779.94 K | 3.65 | -79.39 K | 2.26 | 0.00 | 18.74 M | 10.40 M | 15.19 M | 1.30 | CRITICAL | ||
AGIO | Agios Pharmaceuticals, Inc. | 33.99 0.27 % | -12.4% | Pharma Commercial | — | Endocrinology/Metabolism/Bone, Read More | 2.03 B | 812.04 K | 0.00 | -1.06 M | -6.89 | 0.03 | 964.83 M | 19.10 M | -470.27 M | 49.80 | HEALTHY | |
A AGL | agilon health, inc. | 95.74 -0.38 % | -20.4% | — | — | — | 1.61 B | 155.79 K | 0.00 | -258.23 K | -13.83 | NaN | 185.63 M | 19.10 M | - | 9.20 | CAUTION | |
AGMB | AgomAb Therapeutics NV | 14.28 1.85 % | +13.6% | Biotech Clinical | — | 703.26 M | 243.80 K | 0.00 | - | 0.00 | 0.01 | 101.49 M | - | - | 0.00 | — | ||
AGPU | Axe Compute Inc. | 10.45 0.97 % | +52.5% | N/A (Device) | MedTech | MedTech | 120.12 M | 221.64 K | 0.00 | -74.36 K | -22.05 | 0.04 | 21.91 M | 1.08 M | -28.87 M | 6.42 | PROFITABLE | |
A AHCO | AdaptHealth Corp. Common Stock | 5.67 3.47 % | -49.3% | — | — | — | 773.07 M | 2.26 M | 0.00 | 229.36 K | -1.71 | NaN | 47.96 M | - | - | NaN | PROFITABLE | |
A AHG | Akso Health Group ADS | 0.99 0.59 % | -37.2% | — | — | — | 845.50 M | 3.16 K | 0.00 | - | -0.47 | NaN | - | - | - | NaN | — | |
A AIDX | 20/20 Biolabs, Inc. Common Stock | 0.563 6.59 % | +3.5% | — | — | — | 6.90 M | 69.36 K | 0.00 | - | 0.00 | NaN | 4.55 M | 202.00 K | - | 22.30 | STABLE | |
AIFF | Firefly Neuroscience, Inc. | 1.02 -0.97 % | -9.6% | — | — | — | 16.00 M | 35.95 K | 0.00 | - | -0.58 | 0.00 | 9.23 M | 583.00 K | -8.35 M | 15.50 | STABLE | |
AIM | AIM ImmunoTech Inc. | 0.25 -1.57 % | -7.8% | Biotech Clinical | — | Infectious Disease (viral), On Read More | 7.61 M | 387.67 K | 0.00 | - | -0.47 | 2.15 | 9.96 M | 1.53 M | -9.27 M | 6.00 | CAUTION | |
AIMD | Ainos, Inc. | 1.42 -2.07 % | -15.3% | Biotech Clinical | — | 10.49 M | 7.09 K | 0.00 | 11.44 K | -1.96 | 0.96 | 1.42 M | 483.00 K | -9.81 M | 2.30 | CRITICAL | ||
AIRS | AirSculpt Technologies, Inc. | 2.72 1.87 % | -36.9% | — | — | — | 191.88 M | 833.29 K | 0.00 | - | -0.17 | 0.72 | 18.82 M | 413.00 K | 12.42 M | 45.20 | HEALTHY | |
A AKAN | Akanda Corp. Common Shares | 4.24 -14.34 % | -56.7% | Pharma | — | 2.29 M | 348.26 K | 0.00 | - | 0.00 | NaN | - | - | - | NaN | — | ||
AKBA | Akebia Therapeutics, Inc. | 0.9065 -5.42 % | -37.1% | Pharma Commercial | — | Hematology/Coagulation, Renal Read More | 251.20 M | 14.03 M | 0.00 | -282.68 K | -0.07 | 7.96 | 155.55 M | 5.03 M | 6.57 M | 32.67 | PROFITABLE |